The Variability and Quality of Medication Container Labels

Shrank WH, Agnew-Blais J, Choudhry NK, Wolf MS, Kesselheim AS, Avorn J, Shekelle P - Archives of Internal Medicine

  • Regulation and Clinical Evidence

Summary:

This quantitative study of 85 medication container labels from pharmacies across four cities found that label formatting prioritizes pharmacy identification over medication instructions and warnings, with substantial variability in warning and instruction stickers across pharmacy types. The authors conclude that current labeling practices inadequately emphasize patient safety information and recommend reformatting labels to prioritize use instructions and warnings while standardizing sticker content across pharmacies.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
An icon of a bill representing government policy.

Comments on FDA Discussion Paper, “Considerations for the Regulation of Generative AI-Enabled Medical Devices”

Jaiswal N, Gorijavolu R, Thomas S, Hwang TJ, Celi LA, Kesselheim AS - Food and Drug Administration (FDA)

  • Regulation and Clinical Evidence